Please assess the completion status of the following clinical trial:

Trial Title: Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* adults, aged 21 years or more with either diabetes or metabolic syndrome. metabolic syndrome defined by NCEP/ATPIII criteria; must have 3 out of 5 of the following risk factors: 1.central obesity, men-greater than or equal to 40 inches, women-greater than or equal to 35 inches; 2.fasting blood TG greater than or equal to 150mg/dl or be taking TG lowering medications; 3. blood HDL cholesterol, men less than 40 mg/dl, women less than 50 mg/dl; 4. blood pressure greater than or equal to 130/85 or on HTN medication 5. fasting glucose greater than or equal to 100 mg/dl.~* participants on statins or glucose lowering drugs if dosages are stable for 3 months~Exclusion criteria~* children/young adults less than 21 years of age~* currently using anti-inflammatory drugs including NSAIDS, oral/IV steroids or injection antiinflammatory drugs(for RA), aspirin greater than 100mg/day~* taking leukotriene receptor antagonists ( montelukast), tylenol or nasal/inhaled steroids OK.~* currently using niacin, fibrates or fish oil~* blood pressure greater than 170/100~* HB1Ac greater than 10%~* TG greater than 500 mg/dl~* myocardial infarction/vascular surgery/stroke within the past year~* any stage II,III,IV heart failure~* prior cholecystectomy~* end stage renal disease~* BMI less than 23 or greater than 45~* pregnancy~* alcohol use greater than 14 drinks per week~* current self reported tobacco or illicit drug use~* intolerance or allergy to fish oil~* participants taking insulin on QD or BID doses, stable for 3 months

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- borage and echium oil combination (Type: EXPERIMENTAL): borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA
- fish oil (Type: ACTIVE_COMPARATOR): Croda 18:12 fish oil
- corn oil (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).